Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502240445

Apexbio Technology LLC RN 1734 946387-07-1 10mg
SDP

Catalog No. 502240445
Encompass_Preferred

RN 1734 (CAS 946387-07-1) is a selective antagonist of the TRPV4 ion channel demonstrated to inhibit 4 PDD-induced TRPV4 activation It exhibits low micromolar IC50 values against human (2 3 M) rat (5 9 M) and mouse (3 2 M) TRPV4 indicating high potency across species In experimental models RN 1734 decreases the production of inflammatory cytokines TNF- and IL-1 without affecting the number of oligodendrocyte lineage markers Due to these properties RN 1734 is widely utilized in studies investigating TRPV4 function and the role of this channel in inflammation-related pathologies

This item is not returnable. View return policy
Catalog No. 50-224-0445 Supplier Apexbio Technology LLC Supplier No. B749310
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

RN 1734 (CAS 946387-07-1) is a selective antagonist of the TRPV4 ion channel demonstrated to inhibit 4 PDD-induced TRPV4 activation It exhibits low micromolar IC50 values against human (2 3 M) rat (5 9 M) and mouse (3 2 M) TRPV4 indicating high potency across species In experimental models RN 1734 decreases the production of inflammatory cytokines TNF- and IL-1 without affecting the number of oligodendrocyte lineage markers Due to these properties RN 1734 is widely utilized in studies investigating TRPV4 function and the role of this channel in inflammation-related pathologies

This item is not returnable. View return policy
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.